We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
IDEX Health & Science Announces Acquisition of New Microfluidics Company
News

IDEX Health & Science Announces Acquisition of New Microfluidics Company

IDEX Health & Science Announces Acquisition of New Microfluidics Company
News

IDEX Health & Science Announces Acquisition of New Microfluidics Company

Credit: IDEX Health and Science
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "IDEX Health & Science Announces Acquisition of New Microfluidics Company"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Located in Zweibrücken, Germany, thinXXS Microtechnology is a leader in the development and production of plastic microfluidic consumables serving the Life Sciences, Point of Care, and Veterinary markets. This acquisition will serve to establish IDEX Health & Science as the leader in microfluidic technologies, and sharpen its focus on the growth of integrated optofluidic sub-systems, components, and highly engineered solutions across its target markets.

Commenting on the acquisition, IDEX Health & Science President Gus Salem stated, “thinXXS is our second microfluidic asset acquisition that represents an incremental building block to our microfluidic technologies platform.” Salem continued, “The company’s market-leading technology and product portfolio are a fantastic fit with our microfluidics growth strategy by providing greater access to our core life science instrumentation market and creating new growth opportunities within the Point of Care, and Veterinary markets.”
Advertisement